The pharmaceutical industry export market share in Japan stood at 1.03 in 2023. Forecasted data indicates a gradual decline from 1.02 in 2024 to 0.98 by 2028. This represents year-on-year variations of approximately -0.98% from 2024 to 2025, -0.99% from 2025 to 2026, -1.01% from 2026 to 2027, and -1.01% from 2027 to 2028. The Compound Annual Growth Rate (CAGR) over the five-year period from 2024 to 2028 is -1.24%.
Future trends to watch for include:
- Changes in global pharmaceutical regulations affecting Japan’s export competitiveness.
- Emerging markets' role in absorbing Japan's pharmaceutical exports.
- Innovations in biotechnology and their impact on market dynamics.
- Measures taken by the Japanese government to bolster the pharmaceutical sector's international footprint.
